Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal

Showing results (161-170 of 276) with videos related to

Pageof 28
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 31, 2022
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2015
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with IpilimumabChristoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, et al.
Cancer Research|July 25, 2019
Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 SignalingViktor Fleming, Xiaoying Hu, Céline Weller, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Oncotarget|June 15, 2018
The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physiciansKatharina C Kähler, Christine Blome, Andrea Forschner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 25, 2021
Juliane Weilandt, Katharina Diehl, Marthe-Lisa Schaarschmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 5, 2020
Patient preferences for treatment of advanced melanoma: impact of comorbiditiesJuliane Weilandt, Katharina Diehl, Marthe-Lisa Schaarschmidt, et al.
Frontiers in Immunology|October 31, 2022
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, et al.
Pigment Cell & Melanoma Research|February 10, 2025
A Unique Signature for Cancer-Associated Fibroblasts in Melanoma MetastasesSaskia Tauch, Joschka Hey, Bettina Kast, et al.
Development (Cambridge, England)|December 11, 2012
Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epitheliumAkihiro Hirata, Jochen Utikal, Satoshi Yamashita, et al.
Pageof 28

Showing results (161-170 of 276) with videos related to

Sort By:
Pageof 28
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 31, 2022
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2015
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with IpilimumabChristoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, et al.
Cancer Research|July 25, 2019
Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 SignalingViktor Fleming, Xiaoying Hu, Céline Weller, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Oncotarget|June 15, 2018
The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physiciansKatharina C Kähler, Christine Blome, Andrea Forschner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 25, 2021
Juliane Weilandt, Katharina Diehl, Marthe-Lisa Schaarschmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 5, 2020
Patient preferences for treatment of advanced melanoma: impact of comorbiditiesJuliane Weilandt, Katharina Diehl, Marthe-Lisa Schaarschmidt, et al.
Frontiers in Immunology|October 31, 2022
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, et al.
Pigment Cell & Melanoma Research|February 10, 2025
A Unique Signature for Cancer-Associated Fibroblasts in Melanoma MetastasesSaskia Tauch, Joschka Hey, Bettina Kast, et al.
Development (Cambridge, England)|December 11, 2012
Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epitheliumAkihiro Hirata, Jochen Utikal, Satoshi Yamashita, et al.
Pageof 28